Skip to main content
Livermore
Livermore
ZHEN

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

Holdings in Q1 2024

Holdings as of Mar 31, 2024, filed May 14, 2024. Long positions only; changes compare share counts with Q4 2023.

Institution overview
Positions
77
+4 vs. Q4 2023
Portfolio value
$615.1M
+$113.5M (+22.6%) vs. Q4 2023
Filed
May 14, 2024
SEC
Holdings of Affinity Asset Advisors, LLC in Q1 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
APGEApogee Therapeutics, Inc.COM592,093$39.3M6.4%+55,000+10.2%AddedHistory
XENEXenon Pharmaceuticals Inc.COM837,387$36.0M5.9%+377,387+82.0%AddedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM115,000$30.7M5.0%+15,000+15.0%AddedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM470,000$22.0M3.6%+22,905+5.1%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS3,375,000$21.5M3.5%+1,824,592+117.7%AddedHistory
CLDXCelldex Therapeutics, Inc.COM NEW510,000$21.4M3.5%+110,000+27.5%AddedHistory
ACLXArcellx, Inc.COMMON STOCK300,000$20.9M3.4%−40,000−11.8%ReducedHistory
VERAVera Therapeutics, Inc.CL A470,000$20.3M3.3%+470,000NewHistory
INZYInozyme Pharma, Inc.COM2,642,519$20.2M3.3%+756,717+40.1%AddedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS1,400,000$19.8M3.2%−500,000−26.3%ReducedHistory
BridgeBio Pharma, Inc.10806XAB8NOTE 2.500% 3/1–$18.3M3.0%–––
KURAKura Oncology, Inc.COM730,492$15.6M2.5%+538,957+281.4%AddedHistory
SYRESpyre Therapeutics, Inc.COM NEW410,000$15.6M2.5%−107,554−20.8%ReducedHistory
VRNAVerona Pharma plcSPONSORED ADS817,833$13.2M2.1%+254,009+45.1%AddedHistory
ONCBeOne Medicines Ltd.ADR82,143$12.8M2.1%+82,143NewHistory
CERECerevel Therapeutics Holdings, Inc.COM300,000$12.7M2.1%−450,000−60.0%ReducedHistory
NRIXNurix Therapeutics, Inc.COM810,253$11.9M1.9%+120,141+17.4%AddedHistory
ATXSAstria Therapeutics, Inc.COM845,606$11.9M1.9%−620,859−42.3%ReducedHistory
NUVLNuvalent, Inc.COM150,000$11.3M1.8%−25,000−14.3%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM139,758$11.2M1.8%+89,758+179.5%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM165,000$9.70M1.6%+90,000+120.0%AddedHistory
Alnylam Pharmaceuticals, Inc.02043QAB3NOTE 1.000% 9/1–$9.45M1.5%–New–
CNTACentessa Pharmaceuticals plcSPONSORED ADS830,546$9.39M1.5%+34,817+4.4%AddedHistory
IMVTImmunovant, Inc.COM285,000$9.21M1.5%−60,000−17.4%ReducedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS1,027,868$8.55M1.4%+477,868+86.9%AddedHistory
NARIInari Medical, Inc.Stock175,000$8.40M1.4%+155,000+775.0%AddedHistory
ESTAEstablishment Labs Holdings Inc.COM164,589$8.38M1.4%−63,688−27.9%ReducedHistory
GERNGeron CorpCOM2,500,000$8.25M1.3%+2,500,000NewHistory
MORFMorphic Holding, Inc.COM225,000$7.92M1.3%+182,330+427.3%AddedHistory
Omeros Corp682143AG7NOTE 5.250% 2/1–$7.63M1.2%–––
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES286,200$6.77M1.1%+161,200+129.0%AddedHistory
ELEVElevation Acquisition Group Inc.COM1,268,825$6.51M1.1%+1,268,825NewHistory
CATXPerspective Therapeutics, Inc.COM5,100,000$6.07M1.0%+5,100,000NewHistory
ABSIAbsci CorpCOM1,025,000$5.82M0.9%+1,025,000NewHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$5.78M0.9%–––
SVRASavara IncCOM1,150,000$5.73M0.9%00.0%UnchangedHistory
CYTKCytokinetics IncCOM NEW80,000$5.61M0.9%−80,000−50.0%ReducedHistory
PCVXVaxcyte, Inc.COM80,000$5.46M0.9%+55,000+220.0%AddedHistory
ROIVRoivant Sciences Ltd.SHS500,000$5.27M0.9%00.0%UnchangedHistory
FULCFulcrum Therapeutics, Inc.COM550,339$5.20M0.8%+425,339+340.3%AddedHistory
SWTXSpringWorks Therapeutics, Inc.COM100,000$4.92M0.8%00.0%UnchangedHistory
KRYSKrystal Biotech, Inc.COM26,746$4.76M0.8%+1,746+7.0%AddedHistory
MRSNMersana Therapeutics, Inc.COM1,000,000$4.48M0.7%00.0%UnchangedHistory
CGEMCullinan Therapeutics, Inc.COM258,588$4.41M0.7%−41,412−13.8%ReducedHistory
MLYSMineralys Therapeutics, Inc.COM327,959$4.23M0.7%+327,959NewHistory
VKTXViking Therapeutics, Inc.COM50,000$4.10M0.7%−250,000−83.3%ReducedHistory
RZLTRezolute, Inc.COM NEW1,600,000$4.08M0.7%+1,600,000NewHistory
MIRMMirum Pharmaceuticals, Inc.COM160,000$4.02M0.7%+110,000+220.0%AddedHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD75,000$3.77M0.6%+4,012+5.7%AddedHistory
IMTXImmatics N.V.SHS350,000$3.68M0.6%+150,000+75.0%AddedHistory
ITCIIntra-Cellular Therapies, Inc.COM50,000$3.46M0.6%+50,000NewHistory
ARWRArrowhead Pharmaceuticals, Inc.COM120,000$3.43M0.6%+120,000NewHistory
NXTCNextCure, Inc.COM1,359,037$3.03M0.5%+1,359,037NewHistory
TERNTerns Pharmaceuticals, Inc.COM450,000$2.95M0.5%+384,000+581.8%AddedHistory
PTGXProtagonist Therapeutics, IncCOM100,000$2.89M0.5%+100,000NewHistory
BBOTBridgeBio Oncology Therapeutics, Inc.CL A ORD SHS250,000$2.59M0.4%+250,000NewHistory
RGNXREGENXBIO Inc.COM110,000$2.32M0.4%+110,000NewHistory
NAMSWNewAmsterdam Pharma Co N.V.*W EXP 11/22/202202,599$2.24M0.4%+65,599+47.9%AddedHistory
ALKSAlkermes plc.SHS75,000$2.03M0.3%−281,384−79.0%ReducedHistory
WVEWave Life Sciences, Inc.SHS286,585$1.77M0.3%+286,585NewHistory
BSXBoston Scientific CorpStock25,000$1.71M0.3%+25,000NewHistory
KZRKezar Life Sciences, Inc.COM1,761,778$1.59M0.3%+1,761,778NewHistory
BBIOBridgeBio Pharma, Inc.COM50,000$1.55M0.3%−30,000−37.5%ReducedHistory
ARYDARYA Sciences Acquisition Corp IVCL A133,500$1.50M0.2%+133,500NewHistory
TNGXTango Therapeutics, Inc.COM150,274$1.19M0.2%−150,000−50.0%ReducedHistory
ZURAZura Bio LtdCLASS A ORD SHS450,009$1.16M0.2%+450,009NewHistory
TRMLTourmaline Bio, Inc.COM50,000$1.15M0.2%−18,081−26.6%ReducedHistory
TVTXTravere Therapeutics, Inc.COM125,000$963.8K0.2%+125,000NewHistory
TECXTectonic Therapeutic, Inc.COM700,000$896.0K0.1%+200,000+40.0%AddedHistory
PMNProMIS Neurosciences Inc.COM265,958$508.0K0.1%00.0%UnchangedHistory
Immatics N.V.N44445117*W EXP 07/01/202187,204$486.7K0.1%00.0%Unchanged–
QTTBQ32 Bio Inc.COM27,777$473.3K0.1%+27,777NewHistory
CNTXContext Therapeutics Inc.COM328,817$453.8K0.1%00.0%UnchangedHistory
PASGPassage BIO, Inc.COM264,266$356.8K0.1%+264,266NewHistory
AVTXAvalo Therapeutics, Inc.COM NEW10,000$217.5K<0.1%+10,000NewHistory
Cassava Sciences Inc14817C115*W EXP 11/15/20224,200$97.5K<0.1%+24,200New–
Rocket Pharmaceuticals, Inc.77313F114*W EXP 09/02/20275,000$22.4K<0.1%00.0%Unchanged–

Options (17)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Affinity Asset Advisors, LLC in Q1 2024
SecurityClassPutsCalls
State Street SPDR S&P Biotech ETF78464A870ETF$66.4M–
MRNAModerna, Inc.Stock$42.6M–
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS–$23.4M
IRWDIronwood Pharmaceuticals IncCOM CL A–$8.97M
BBIOBridgeBio Pharma, Inc.COM–$7.73M
GRTSGritstone bio, Inc.COM$6.14M–
ALNYAlnylam Pharmaceuticals, Inc.COM–$5.98M
RAPTRAPT Therapeutics, Inc.COM$5.18M$538.8K
GHGuardant Health, Inc.COM–$5.16M
IMVTImmunovant, Inc.COM–$4.67M
CRSPCRISPR Therapeutics AGNAMEN AKT–$4.43M
IBRXImmunityBio, Inc.COM$3.17M–
FULCFulcrum Therapeutics, Inc.COM–$2.60M
ESTAEstablishment Labs Holdings Inc.COM–$2.54M
AKROAkero Therapeutics, Inc.COM–$1.89M
ANVSAnnovis Bio, Inc.COM$867.5K–
CBIOCrescent Biopharma, Inc.COM$426.9K–

Sold out since Q4 2023 (21)

Positions held at the end of Q4 2023 that are gone from this filing.

Positions of Affinity Asset Advisors, LLC sold out since Q4 2023
SecurityClassShares in Q4 2023Value in Q4 2023% of portfolio in Q4 2023History
IMGNImmunoGen, Inc.COM1,404,608$41.6M8.3%History
CBAYCymaBay Therapeutics, Inc.COM1,090,441$25.8M5.1%History
LIANYLianBioSPONSORED ADS3,779,694$16.9M3.4%History
MRTXMirati Therapeutics, Inc.COM100,049$5.88M1.2%History
DVAXDynavax Technologies CorpCOM NEW300,000$4.19M0.8%History
AZNAstraZeneca PLCSPONSORED ADR60,000$4.04M0.8%History
RLAYRelay Therapeutics, Inc.COM300,000$3.30M0.7%History
ARGXArgenx SESPONSORED ADR7,500$2.85M0.6%History
EYPTEyePoint, Inc.COM NEW109,900$2.54M0.5%History
ASNDAscendis Pharma A/SSPONSORED ADR20,000$2.52M0.5%History
PENPenumbra IncCOM7,500$1.89M0.4%History
ADCTADC Therapeutics SASHS1,013,540$1.68M0.3%History
KALVKalVista Pharmaceuticals, Inc.COM125,969$1.54M0.3%History
NBIXNeurocrine Biosciences IncStock10,000$1.32M0.3%History
ALLOAllogene Therapeutics, Inc.COM400,000$1.28M0.3%History
VRDNViridian Therapeutics, Inc.COM50,000$1.09M0.2%History
BHVNBiohaven Ltd.COM20,866$893.1K0.2%History
PBYIPuma Biotechnology, Inc.COM202,349$876.2K0.2%History
NUVBNuvation Bio Inc.COM CL A250,000$377.5K0.1%History
IFRXInflaRx N.V.COM200,097$326.2K0.1%History
ARAVAravive, Inc.COM346,511$42.9K<0.1%History